Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Farmacotherapie bij diabetische perifere neuropathie: een systematische review
jul 2017 | Diabetes